Human Research Protection Office

Fingerprint Dive into the research topics where Human Research Protection Office is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

    Merryman, R. W., Edwin, N., Redd, R., Bsat, J., Chase, M., LaCasce, A., Freedman, A., Jacobson, C., Fisher, D., Ng, S., Crombie, J., Kim, A., Odejide, O., Davids, M. S., Brown, J. R., Jacene, H., Cashen, A., Bartlett, N. L., Mehta-Shah, N., Ghobadi, A. & 4 others, Kahl, B., Joyce, R., Armand, P. & Jacobsen, E., Mar 10 2020, In : Blood Advances. 4, 5, p. 858-867 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT

    Badar, T., Epperla, N., Szabo, A., Borson, S., Vaughn, J., George, G., Saini, N., Shah, A. R., Patel, R. D., Ahmed, S., Shah, N. N., Cashen, A. F., Hamadani, M. & Fenske, T. S., Jan 14 2020, In : Blood Advances. 4, 1, p. 41-54 14 p.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations

    10-day decitabine schedule in acute myeloid leukaemia: no extra bang for the buck

    Cashen, A. F., Jan 2019, In : The Lancet Haematology. 6, 1, p. e6-e7

    Research output: Contribution to journalComment/debate